Børge Sørvoll
Fortuna: 244 676 $ al 31/05/2026
Fortuna: 244 676 $ al 31/05/2026
Børge Sørvoll currently works at Biotec BetaGlucans AS, as Chairman and ArcticZymes Technologies ASA, as Chief Financial Officer from 2014.
Mr. Sørvoll also formerly worked at Troms Kraft Invest AS, as Managing Director & Chief Financial Officer, Front Exploration AS, as Chief Financial Officer, and Subsea 7 Norway AS, as Manager.
Mr. Sørvoll received his undergraduate degree from the University of Wyoming.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/12/2024 | 100.428 ( 0,2 % ) | 244 676 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ARCTICZYMES TECHNOLOGIES ASA | Director Financiero/CFO | 01/10/2014 |
Biotec BetaGlucans AS
Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Develops and manufactures immune modulating compounds for the human health sectors | Presidente | - |
| Empresas | Cargo | Fin |
|---|---|---|
Front Exploration AS
Front Exploration AS Contract DrillingIndustrial Services Explores oil and gas | Director Financiero/CFO | - |
Subsea 7 Norway AS
Subsea 7 Norway AS Miscellaneous Commercial ServicesCommercial Services Engages in general trading activities | Corporate Officer/Principal | - |
Troms Kraft Invest AS | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
University of Wyoming
University of Wyoming Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ArcticZymes Technologies ASA
ArcticZymes Technologies ASA Medical SpecialtiesHealth Technology Develops and manufactures immune modulating compounds | Health Technology |
Front Exploration AS
Front Exploration AS Contract DrillingIndustrial Services Explores oil and gas | Industrial Services |
Subsea 7 Norway AS
Subsea 7 Norway AS Miscellaneous Commercial ServicesCommercial Services Engages in general trading activities | Commercial Services |
Troms Kraft Invest AS | |
Biotec BetaGlucans AS
Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Develops and manufactures immune modulating compounds for the human health sectors | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.